Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in Relapsed/Refractory PTCL
NCT07093710Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of golidocitinib in peripheral T-cell lymphoma (PTCL), sponsored by Sun Yat-sen University. Started Aug 2025; status: recruiting.
02
Drugs
golidocitinib
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT07093710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07093710.